These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 11205460
1. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Matsuyama Y, Tominaga T, Nomura Y, Koyama H, Kimura M, Sano M, Miura S, Takashima S, Mitsuyama S, Ueo H, Ohashi Y. Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460 [Abstract] [Full Text] [Related]
2. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N. J Natl Cancer Inst; 1995 May 03; 87(9):645-51. PubMed ID: 7752269 [Abstract] [Full Text] [Related]
7. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. Cook LS, Weiss NS, Schwartz SM, White E, McKnight B, Moore DE, Daling JR. J Natl Cancer Inst; 1995 Sep 20; 87(18):1359-64. PubMed ID: 7658496 [Abstract] [Full Text] [Related]
9. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma. Katase K, Sugiyama Y, Hasumi K, Yoshimoto M, Kasumi F. Cancer; 1998 May 01; 82(9):1698-703. PubMed ID: 9576291 [Abstract] [Full Text] [Related]
10. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients. Robinson DC, Bloss JD, Schiano MA. Gynecol Oncol; 1995 Nov 01; 59(2):186-90. PubMed ID: 7590470 [Abstract] [Full Text] [Related]
11. Tamoxifen and risk of large bowel cancer in women with breast cancer. Newcomb PA, Solomon C, White E. Breast Cancer Res Treat; 1999 Feb 01; 53(3):271-7. PubMed ID: 10369073 [Abstract] [Full Text] [Related]
14. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE. Lancet; 2000 Sep 09; 356(9233):881-7. PubMed ID: 11036892 [Abstract] [Full Text] [Related]
15. Re: second cancers after adjuvant tamoxifen therapy for breast cancer. Rutqvist LE. J Natl Cancer Inst; 1996 Oct 16; 88(20):1497-9; author reply, 1497-9. PubMed ID: 8841030 [No Abstract] [Full Text] [Related]
17. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy. Wright JD, Desai VB, Chen L, Burke WM, Tergas AI, Hou JY, Accordino M, Ananth CV, Neugut AI, Hershman DL. Am J Obstet Gynecol; 2017 Jul 16; 217(1):59.e1-59.e12. PubMed ID: 28341383 [Abstract] [Full Text] [Related]
18. Risk of new primaries after chemotherapy and/or tamoxifen treatment for early breast cancer. Rubagotti A, Perrotta A, Casella C, Boccardo F. Ann Oncol; 1996 Mar 16; 7(3):239-44. PubMed ID: 8740786 [Abstract] [Full Text] [Related]
19. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC). Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J, Fondrinier E, Lefeuvre C, Parache RM, Chauvin F. Int J Cancer; 1998 May 04; 76(3):325-30. PubMed ID: 9579567 [Abstract] [Full Text] [Related]
20. Tamoxifen and the risk of endometrial cancer in Japanese women with breast cancer. Yamazawa K, Miyazawa Y, Suzuki M, Wakabayashi M, Kaku H, Matsui H, Sekiya S. Surg Today; 2006 May 04; 36(1):41-6. PubMed ID: 16378192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]